VA Documents Detail Schedule III Cannabis Limits on Veteran Access

Schedule III Status Does Not Trigger VA Prescribing Authority

The VA documents clarify that Schedule III classification—the target of the Drug Enforcement Administration's pending rescheduling proposal—would leave intact 38 U.S.C. § 7332 restrictions barring VA clinicians from recommending cannabis. Under current VA policy, physicians may discuss cannabis use with patients. But they can't provide formal recommendations or certifications required by state medical cannabis programs.

The guidance circulated to VA medical centers in May 2026. It addresses confusion among providers following the DEA's publication of its Notice of Proposed Rulemaking in December 2024, which proposed moving cannabis from Schedule I to Schedule III of the CSA—a change finalized in administrative hearings earlier this year.

Federal Employment Law Blocks VA Participation in State Programs

VA attorneys concluded that even Schedule III substances remain federally controlled, and federal employees can't facilitate their distribution under state law. The legal analysis cites 21 U.S.C. § 812, which establishes scheduling criteria but doesn't exempt federal agencies from CSA compliance.

VA physicians who provide written recommendations could face disciplinary action under federal employment rules, the memo notes. This interpretation aligns with the Department of Justice's 2011 guidance to U.S. Attorneys, which distinguished state-authorized medical cannabis programs from federal enforcement priorities but didn't authorize federal employee participation.

Veterans Health Administration Confirms No Policy Change Planned

The Veterans Health Administration stated it has no plans to revise its cannabis policy following rescheduling. According to the internal documents, the VHA's Office of Patient Care Services reviewed the rescheduling proposal and determined that Schedule III status doesn't trigger any statutory or regulatory change in VA prescribing authority.

VA Directive 1315 currently permits clinicians to document cannabis use in patient records and adjust treatment plans accordingly, but stops short of authorizing recommendations. That directive remains in effect.

State Medical Cannabis Programs Require Physician Certification

All 38 states with medical cannabis programs require a physician's written certification or recommendation to qualify patients for legal access. Veterans who seek state medical cannabis cards must obtain those certifications from non-VA providers. This creates a fragmented care model that complicates treatment for conditions like PTSD and chronic pain.

Veterans may use cannabis and remain eligible for VA care, the documents note, but the agency can't facilitate access through state programs. For comprehensive context on the federal rescheduling process and its limitations, see the CannIntel topic hub on DEA rescheduling.

Congressional Bills to Expand VA Cannabis Authority Stalled

Legislation that would explicitly authorize VA physicians to recommend medical cannabis hasn't advanced in the current Congress. The Veterans Medical Marijuana Safe Harbor Act, introduced in 2025, would amend 38 U.S.C. § 7332 to permit recommendations in states with legal programs. It remains in committee.

Separate legislation, the VA Medicinal Cannabis Research Act, would authorize VA-funded clinical trials. That bill has bipartisan co-sponsors but hasn't received a floor vote.

Veteran Advocacy Groups Press for Legislative Fix

Veterans advocacy organizations including Iraq and Afghanistan Veterans of America and the American Legion have called for statutory changes to align VA policy with state medical cannabis laws. IAVA's policy director stated in May 2026 that rescheduling alone wouldn't address the gap between state programs and federal restrictions on VA care.

In 2023, the American Legion passed a resolution supporting VA physician authority to recommend cannabis in states where it's legal. The group has lobbied Congress to include VA cannabis provisions in the annual National Defense Authorization Act, without success to date.